3-amino-N-[1-(6-chloro-1H-benzimidazol-2-yl)ethyl]-4-[2-(2-phenylethyl)pyrrolidine-1-carbonyl]benzamide

C29H30ClN5O2 — CID 142911617

IUPAC3-amino-N-[1-(6-chloro-1H-benzimidazol-2-yl)ethyl]-4-[2-(2-phenylethyl)pyrrolidine-1-carbonyl]benzamide
SMILESCC(NC(=O)c1ccc(C(=O)N2CCCC2CCc2ccccc2)c(N)c1)c1nc2ccc(Cl)cc2[nH]1
InChIInChI=1S/C29H30ClN5O2/c1-18(27-33-25-14-11-21(30)17-26(25)34-27)32-28(36)20-10-13-23(24(31)16-20)29(37)35-15-5-8-22(35)12-9-19-6-3-2-4-7-19/h2-4,6-7,10-11,13-14,16-18,22H,5,8-9,12,15,31H2,1H3,(H,32,36)(H,33,34)
InChIKeyJJSPSJUQTUKBOI-UHFFFAOYSA-N
MW516.05 g/mol
LogP5.53
Rot. Bonds7

About 3-amino-N-[1-(6-chloro-1H-benzimidazol-2-yl)ethyl]-4-[2-(2-phenylethyl)pyrrolidine-1-carbonyl]benzamide

3-amino-N-[1-(6-chloro-1H-benzimidazol-2-yl)ethyl]-4-[2-(2-phenylethyl)pyrrolidine-1-carbonyl]benzamide (PubChem CID 142911617) has the molecular formula C29H30ClN5O2 and a molecular weight of 516.05 g/mol. Its IUPAC name is 3-amino-N-[1-(6-chloro-1H-benzimidazol-2-yl)ethyl]-4-[2-(2-phenylethyl)pyrrolidine-1-carbonyl]benzamide.

Molecular Properties

Compound Name3-amino-N-[1-(6-chloro-1H-benzimidazol-2-yl)ethyl]-4-[2-(2-phenylethyl)pyrrolidine-1-carbonyl]benzamide
PubChem CID142911617
Molecular FormulaC29H30ClN5O2
Molecular Weight516.05 g/mol
Exact Mass515.21
IUPAC Name3-amino-N-[1-(6-chloro-1H-benzimidazol-2-yl)ethyl]-4-[2-(2-phenylethyl)pyrrolidine-1-carbonyl]benzamide
SMILESCC(NC(=O)c1ccc(C(=O)N2CCCC2CCc2ccccc2)c(N)c1)c1nc2ccc(Cl)cc2[nH]1
InChIInChI=1S/C29H30ClN5O2/c1-18(27-33-25-14-11-21(30)17-26(25)34-27)32-28(36)20-10-13-23(24(31)16-20)29(37)35-15-5-8-22(35)12-9-19-6-3-2-4-7-19/h2-4,6-7,10-11,13-14,16-18,22H,5,8-9,12,15,31H2,1H3,(H,32,36)(H,33,34)
InChIKeyJJSPSJUQTUKBOI-UHFFFAOYSA-N
XLogP5.53
TPSA104.11 Ų
H-Bond Donors3
H-Bond Acceptors4
Rotatable Bonds7
Heavy Atoms37
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500516.05
LogP ≤ 55.53
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 104

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'aniline', 'substructure': 'N/A'}

Analyze 3-amino-N-[1-(6-chloro-1H-benzimidazol-2-yl)ethyl]-4-[2-(2-phenylethyl)pyrrolidine-1-carbonyl]benzamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 3-amino-N-[1-(6-chloro-1H-benzimidazol-2-yl)ethyl]-4-[2-(2-phenylethyl)pyrrolidine-1-carbonyl]benzamide?
The IUPAC name of 3-amino-N-[1-(6-chloro-1H-benzimidazol-2-yl)ethyl]-4-[2-(2-phenylethyl)pyrrolidine-1-carbonyl]benzamide (CID 142911617) is 3-amino-N-[1-(6-chloro-1H-benzimidazol-2-yl)ethyl]-4-[2-(2-phenylethyl)pyrrolidine-1-carbonyl]benzamide.
What is the SMILES notation for 3-amino-N-[1-(6-chloro-1H-benzimidazol-2-yl)ethyl]-4-[2-(2-phenylethyl)pyrrolidine-1-carbonyl]benzamide?
The canonical SMILES for 3-amino-N-[1-(6-chloro-1H-benzimidazol-2-yl)ethyl]-4-[2-(2-phenylethyl)pyrrolidine-1-carbonyl]benzamide is CC(NC(=O)c1ccc(C(=O)N2CCCC2CCc2ccccc2)c(N)c1)c1nc2ccc(Cl)cc2[nH]1.
What is the InChIKey of 3-amino-N-[1-(6-chloro-1H-benzimidazol-2-yl)ethyl]-4-[2-(2-phenylethyl)pyrrolidine-1-carbonyl]benzamide?
The InChIKey is JJSPSJUQTUKBOI-UHFFFAOYSA-N. The full InChI is InChI=1S/C29H30ClN5O2/c1-18(27-33-25-14-11-21(30)17-26(25)34-27)32-28(36)20-10-13-23(24(31)16-20)29(37)35-15-5-8-22(35)12-9-19-6-3-2-4-7-19/h2-4,6-7,10-11,13-14,16-18,22H,5,8-9,12,15,31H2,1H3,(H,32,36)(H,33,34).
What are the key properties of 3-amino-N-[1-(6-chloro-1H-benzimidazol-2-yl)ethyl]-4-[2-(2-phenylethyl)pyrrolidine-1-carbonyl]benzamide?
3-amino-N-[1-(6-chloro-1H-benzimidazol-2-yl)ethyl]-4-[2-(2-phenylethyl)pyrrolidine-1-carbonyl]benzamide has a molecular weight of 516.05 g/mol, XLogP of 5.53, 7 rotatable bonds, 3 hydrogen bond donors, and 4 hydrogen bond acceptors.
Where does this data come from?
All data for 3-amino-N-[1-(6-chloro-1H-benzimidazol-2-yl)ethyl]-4-[2-(2-phenylethyl)pyrrolidine-1-carbonyl]benzamide is sourced from PubChem (CID 142911617), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).